Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Peter D Arkwright"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 584-596 (2024)
Introduction Rotavirus is a leading cause of severe diarrheal disease and death in children under five years of age worldwide. Vaccination is one of the most important public health interventions to reduce this significant burden.Areas covered This l
Externí odkaz:
https://doaj.org/article/4ef3cbb2f8124cd89202124fdd3c093c
Autor:
Deepika Roshith, Christopher Rawlingson, Timothy H. Clayton, Chitra Sethuraman, Peter D. Arkwright
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 4, Pp 1244-1247 (2024)
Abstract Neutrophilic dermatoses are autoinflammatory disorders characterised by sterile cutaneous inflammatory neutrophilic infiltrates. This group of diseases is rare in infants and children, where sepsis is the diagnosis of exclusion. This report
Externí odkaz:
https://doaj.org/article/d2951911ea0041eca8d5f8fc437cb873
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 226-242 (2023)
Introduction Despite children aged 6–35 months developing more severe influenza infections, not all countries include influenza vaccines in their national immunization programs. Areas covered This literature review examines the efficacy, immunogeni
Externí odkaz:
https://doaj.org/article/1d2501672f8a40429307bcf3c956a3f8
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 104-117 (2023)
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b. Areas Covered To e
Externí odkaz:
https://doaj.org/article/dfba5fd16e6f4a79b95554600d27f68d
Autor:
Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2697-2719 (2023)
Abstract Background For children aged 6–11 years with uncontrolled severe atopic dermatitis (AD), 16 weeks of treatment with dupilumab resulted in substantial clinical benefit compared with placebo with an acceptable safety profile. However, longer
Externí odkaz:
https://doaj.org/article/4dab87121bb04ebfa5a3e58c15eea599
Autor:
Elaine C. Siegfried, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Lara Wine Lee, Zhen Chen, Randy Prescilla, Ashish Bansal, Noah A. Levit, Ainara Rodríguez Marco
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 9, Pp 1987-2000 (2023)
Abstract Introduction Atopic dermatitis (AD) is heterogeneous in distribution pattern and clinical features. This analysis assessed the effect of dupilumab on the extent and severity of AD across various signs (erythema, edema/papulation, excoriation
Externí odkaz:
https://doaj.org/article/7f9dd1149078422ab5b7d8705d2ca580
Autor:
Nina Jahnich, Peter D. Arkwright
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis (TB) and viral hepatitis B are considered potential infectious complications, and screening and surveillance are therefore recommended. Current guidelines do n
Externí odkaz:
https://doaj.org/article/fb1cc9b41b814a5dab54bbdbdeb405c8
Autor:
Thomas Proctor, Elodie Morrough, Otto Fenske, Sarah Allatt, Stephen M. Hughes, Vibha Sharma, Peter D. Arkwright
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-9 (2020)
Abstract Background Pollen and house dust mite (HDM) subcutaneous immunotherapy (SLIT) and pollen subcutaneous immunotherapy (SCIT) are effective therapies for children with allergic rhinoconjunctivitis (AR). There are no previous direct comparative
Externí odkaz:
https://doaj.org/article/7a480cd10f924ca5a9581aa2a0c06931
Autor:
Matthew Greenhawt, Sayantani B. Sindher, Julie Wang, Michael O’Sullivan, George du Toit, Edwin H. Kim, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D. Arkwright, Philippe Bégin, Katharina Blumchen, Thierry Bourrier, Terri Brown-Whitehorn, Heather Cassell, Edmond S. Chan, Christina E. Ciaccio, Antoine Deschildre, Amandine Divaret-Chauveau, Stacy L. Dorris, Morna J. Dorsey, Thomas Eiwegger, Michel Erlewyn-Lajeunesse, David M. Fleischer, Lara S. Ford, Maria Garcia-Lloret, Lisa Giovannini-Chami, Jonathan O. Hourihane, Nicola Jay, Stacie M. Jones, Leigh Ann Kerns, Kirsten M. Kloepfer, Stephanie Leonard, Guillaume Lezmi, Jay A. Lieberman, Jeanne Lomas, Melanie Makhija, Christopher Parrish, Jane Peake, Kirsten P. Perrett, Daniel Petroni, Wolfgang Pfützner, Jacqueline A. Pongracic, Patrick Quinn, Rachel G. Robison, Georgiana Sanders, Lynda Schneider, Hemant P. Sharma, Juan Trujillo, Paul J. Turner, Katherine Tuttle, Julia E. Upton, Pooja Varshney, Brian P. Vickery, Christian Vogelberg, Brynn Wainstein, Robert A. Wood, Katharine J. Bee, Dianne E. Campbell, Todd D. Green, Rihab Rouissi, Aurélie Peillon, Henry T. Bahnson, Timothée Bois, Hugh A. Sampson, A. Wesley Burks
Publikováno v:
New England Journal of Medicine, 388(19), 1755-1766. Massachussetts Medical Society
Background No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown. Methods We conducted this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deff0c9eb3945f677231931ba9857c3b
https://doi.org/10.1056/NEJMoa2212895
https://doi.org/10.1056/NEJMoa2212895
Autor:
Peter D, Arkwright, Jennifer J, Koplin
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 11:63-71
The last decade has seen an unprecedented pace of change, particularly of clinical research in atopic dermatitis (AD). This review summarizes some key discoveries. Over the last 10 years, nearly half of all studies investigated the efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f38c50258d2d2eb11e2bac4e273df18
https://doi.org/10.1016/j.jaip.2022.09.021
https://doi.org/10.1016/j.jaip.2022.09.021